35 Appendix 2, Regulation (EU) 2019/1390

In forcesince 31 Jul 2019

Test Components |

EpiOcular™ EIT

(VRM 1)

SkinEthic™ HCE EIT

(VRM 2)

Protocols |

Liquids

(pipetteable at 37±1 °C or lower temperatures for 15 min)

Solids

(not pipetteable)

Liquids and viscous

(pipetteable)

Solids

(not pipetteable)

Model surface | 0,6 cm2 | 0,6 cm2 | 0,5 cm2 | 0,5 cm2

Number of tissue replicates | At least 2 | At least 2 | At least 2 | At least 2

Pre-check for colour interference |

50 μl + 1 ml H2O for 60 min at 37±2 °C, 5±1 % CO2, ≥95 % RH (non-coloured test chemicals), or 50 μl + 2 ml isopropanol mixed for 2-3h at RT (coloured test chemicals)

if the OD of the test chemical at 570±20 nm, after subtraction of the OD for isopropanol or water is > 0.08 (which corresponds to approximately 5 % of the mean OD of the negative control), living adapted controls should be performed.

50 mg + 1 ml H2O for 60 min at 37±2 °C, 5±1 % CO2, ≥95 % RH(non-coloured test chemicals)

and/or

50 mg + 2 ml isopropanol mixed for 2-3h at RT (colored and non-colored test chemicals)

if the OD of the test chemical at 570±20 nm after subtraction of the OD for isopropanol or water is > 0.08 (which corresponds to approximately 5 % of the mean OD of the negative control), living adapted controls should be performed.

10 μl + 90 μl H2O mixed for 30±2 min at Room Temperature (RT, 18-28 °C)

if test chemical is coloured, living adapted controls should be performed

10 mg + 90 μl H2O mixed for 30±2 min at RT

if test chemical is coloured, living adapted controls should be performed

Pre-check for direct MTT reduction |

50 μl + 1 ml MTT 1 mg/ml solution for 180±15 min at 37±2 °C, 5±1 % CO2, ≥95 % RH

if solution turns blue/purple, freeze-killed adapted controls should be performed

(50 μl of sterile deionised water in MTT solution is used as negative control)

50 mg + 1 ml MTT 1 mg/ml solution for 180±15 min at 37±2 °C, 5±1 % CO2, ≥95 % RH

if solution turns blue/purple, freeze-killed adapted controls should be performed

(50 μl of sterile deionised water in MTT solution is used as negative control)

30 μl + 300 μl MTT 1 mg/ml solution for 180±15 min at 37±2 °C, 5±1 % CO2, ≥95 % RH

if solution turns blue/purple, water-killed adapted controls should be performed

(30 μl of sterile deionised water in MTT solution is used as negative control)

30 mg + 300 μl MTT 1 mg/ml solution for 180±15 min at 37±2 °C, 5±1 % CO2, ≥95 % RH

if solution turns blue/purple, water-killed adapted controls should be performed

(30 μl of sterile deionised water in MTT solution is used as negative control)

Pre-treatment |

20 μl Ca2+/Mg2+-free DPBS

for 30 ± 2 min at 37±2 °C, 5±1 % CO2, ≥95 % RH, protected from light.

20 μl Ca2+/Mg2+-free DPBS

for 30±2 min at 37±2 °C, 5±1 % CO2, ≥95 % RH, protected from light.

–

| —

Treatment doses and application | 50 μl (83,3 μl/cm2) | 50 mg (83,3 mg/cm2) using a calibrated tool (e.g. a levelled spoonful calibrated to hold 50 mg of sodium chloride). |

10 μl Ca2+/Mg2+-free DPBS + 30 ± 2 μl (60 μl/cm2)

For viscous, use a nylon mesh

30 μl Ca2+/Mg2+-free DPBS + 30 ± 2 mg (60 mg/cm2)

Exposure time and temperature |

30 min (± 2 min)

in culture medium

at 37±2 °C, 5±1 % CO2, ≥95 % RH

6 hours (± 0.25 h)

in culture medium

at 37±2 °C, 5±1 % CO2, ≥95 % RH

30 min (± 2 min)

in culture medium

at 37±2 °C, 5±1 % CO2, ≥95 % RH

4 hours (± 0.1 h)

in culture medium

at 37±2 °C, 5±1 % CO2, ≥95 % RH

Rinsing at room temperature | 3 times in 100 ml of Ca2+/Mg2+-free DPBS | 3 times in 100 ml of Ca2+/Mg2+-free DPBS | 20 ml Ca2+/Mg2+-free DPBS | 25 ml Ca2+/Mg2+-free DPBS

Post-exposure immersion | 12 min (± 2 min) at RT in culture medium | 25 min (± 2 min) at RT in culture medium | 30 min (± 2 min) at 37 °C, 5 % CO2, 95 % RH in culture medium | 30 min (± 2 min) at RT in culture medium

Post-exposure incubation | 120 min (± 15 min) in culture medium at 37±2 °C, 5±1 % CO2, ≥95 % RH | 18 h (± 0,25 h) in culture medium at 37±2 °C, 5±1 % CO2, ≥95 % RH | none | 18 h (± 0,5 h) in culture medium at 37±2 °C, 5±1 % CO2, ≥95 % RH

Negative control |

50 μl H2O

Tested concurrently

50 μl H2O

Tested concurrently

30 ± 2 μl Ca2+/Mg2+-free DPBS

Tested concurrently

30 ± 2 μl Ca2+/Mg2+-free DPBS

Tested concurrently

Positive control |

50 μl Methyl acetate

Tested concurrently

50 μl Methyl acetate

Tested concurrently

30 ± 2 μl Methyl acetate

Tested concurrently

30 ± 2 μl Methyl acetate

Tested concurrently

MTT solution | 300 μl 1 mg/ml | 300 μl 1 mg/ml | 300 μl 1 mg/ml | 300 μl 1 mg/ml

MTT incubation time and temperature | 180 min (± 15 min) at 37±2 °C, 5±1 % CO2, ≥95 % RH | 180 min (± 15 min) at 37±2 °C, 5±1 % CO2, ≥95 % RH | 180 min (± 15 min) at 37±2 °C, 5±1 % CO2, ≥95 % RH | 180 min (± 15 min) at 37±2 °C, 5±1 % CO2, ≥95 % RH

Extraction solvent |

2 ml isopropanol

(extraction from top and bottom of insert by piercing the tissue)

2 ml isopropanol

(extraction from bottom of insert by piercing the tissue)

1.5 ml isopropanol

(extraction from top and bottom of insert)

1.5 ml isopropanol

(extraction from bottom of insert)

Extraction time and temperature | 2-3 h with shaking (~120 rpm) at RT or overnight at 4-10 °C | 2-3 h with shaking (~120 rpm) at RT or overnight at 4-10 °C | 4 h with shaking (~120 rpm) at RT or at least overnight without shaking at 4-10 °C | At least 2 h with shaking (~120 rpm) at RT

OD reading |

570 nm (550 - 590 nm)

without reference filter

570 nm (550 - 590 nm)

without reference filter

570 nm (540 - 600 nm)

without reference filter

570 nm (540 - 600 nm)

without reference filter

Tissue Quality Control |

Treatment with 100 μl of 0,3 % (v/v) Triton X-100

12.2 min ≤ ET50 ≤ 37,5 min

Treatment with 100 μl of 0,3 % (v/v) Triton X-100

12.2 min ≤ ET50 ≤ 37,5 min

30 min treatment with SDS (50 μl)

1,0 mg/ml ≤ IC50 ≤ 3,5 mg/ml

30 min treatment with SDS (50 μl)

1,0 mg/ml ≤ IC50 ≤ 3,2 mg/ml

Acceptance Criteria |

1.

Mean OD of the tissue replicates treated with the negative control should be > 0,8 and < 2,5

2.

Mean viability of the tissue replicates exposed for 30 min with the positive control, expressed as % of the negative control, should be < 50 %

3.

The difference of viability between two tissue replicates should be less than 20 %.

1.

Mean OD of the tissue replicates treated with the negative control should be > 0.8 and < 2.5

2.

Mean viability of the tissue replicates exposed for 6 hours with the positive control, expressed as % of the negative control, should be < 50 %

3.

The difference of viability between two tissue replicates should be less than 20 %.

1.

Mean OD of the tissue replicates treated with the negative control should be > 1.0 and ≤ 2.5

2.

Mean viability of the tissue replicates exposed for 30 min with the positive control, expressed as % of the negative control, should be ≤ 30 %

3.

The difference of viability between two tissue replicates should be less than 20 %.

1.

Mean OD of the tissue replicates treated with the negative control should be > 1.0 and ≤ 2.5

2.

Mean viability of the tissue replicates exposed for 4 hours with the positive control, expressed as % of the negative control, should be ≤ 20 %

3.

The difference of viability between two tissue replicates should be less than 20 %.